Risk factors for venous thromboembolism in patients with chronic kidney disease: a systematic review and meta-analysis
Year: 2024
Type: review
Study designs: Systematic Review, Meta-Analysis
Abstract: Purpose The objective of this study was to conduct a meta-analysis and systematic review to identify the risk factors contributing to thromboembolism (VTE) in chronic kidney disease (CKD) patients.Methods PubMed, Cochrane Library, Web of Science, and Embase databases were searched from inception to October 2024. Cohort, case-control, and cross-sectional studies examining risk factors for VTE in CKD were included. Quality assessment and data extraction were conducted.Results Fourteen studies were analyzed. CKD stage 2 (OR: 1.15, 95% CI: 1.06–1.25, p < .01), CKD stage 3 (OR: 2.28, 95% CI: 1.76–2.95, p < .01), CKD stage 3–4 (OR: 1.57, 95% CI: 1.17–2.1, p < .01), end-stage renal disease (OR: 3.68, 95% CI: 1.02–13.27, p < .01), female (OR: 1.30, 95% CI: 1.15–1.48, p < .01), congestive heart failure (CHF) (OR: 1.26, 95% CI: 1.09–1.46, p < .01), atrial fibrillation (AF) (OR: 1.97, 95% CI: 1.40–2.97, p < .01), coronary artery disease (CAD) (OR: 1.28, 95% CI: 1.05–1.56, p = .01), and systemic lupus erythematosus (SLE) (OR: 3.06, 95% CI: 1.57–5.94, p < .01) were associated with increased risk of VTE. In addition, in sensitivity analyses, hemodialysis increased the risk of VTE compared with peritoneal dialysis (OR: 2.35, 95% CI: 1.34–4.14, p < .01).Conclusions Different CKD stages, female, CHF, AF, CAD, and SLE emerge as significant risk factors for VTE in CKD patients. Additionally, VTE risk can be influenced by dialysis modality and other factors. Physicians should comprehensively assess the risk of VTE in patients with CKD.
Source: Renal Failure
Authors: Ya Zhan, Xinwei Fu, Weihong Bi, Guisen Li
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,306
OpenAlex ID: W4404699028